-
Alnylam Pharmaceuticals Dips Lower After Company Announces 2016 Pipeline Goals Towards 'Alnylam 2020'
Monday, January 11, 2016 - 2:57pm | 171Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) were trading lower by nearly 7 percent at $78.74 mid-Monday afternoon after the company announced its pipeline goals for 2016 across its various segments. Alnylam Pharmaceuticals noted that by the end of 2020 it expects to achieve a profile...
-
Shares Of Alnylam Pharmaceuticals Lower Following Equity Offering
Wednesday, January 21, 2015 - 11:03am | 109Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) tumbled 4 percent Wednesday morning as the company priced 4.73 million shares of common stock at $95 per share after announcing on Tuesday it plans to initiate a public offering of common stock. All of the shares being offering will be sold by...